Scroll To Top
Search by Speciality

10th Australian Peptide Conference

Golden Sands Resort * | Penang, MALAYSIA
From 350 to 740 AUD
Event Preview
This event
is Finished
Title: 10th Australian Peptide Conference
Specialty: , Clinical Biochemistry, Endocrinology
Dates: From Sep, 8, 2013 to Sep, 13, 2013
Location: Penang, MALAYSIA
Type: Conference
Registration Cost: From 350 to 740 AUD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Penang, Malaysia.
General Info
Event Venue:

Golden Sands Resort *

Penang, MALAYSIA Visit the Venue to read more
Transportation Guide:

Airport Transfers

As per below, there are a number of airport transfer options to provide you with a safe and easy way to get to the Shangri-La Golden Sands Resort.

If you would like to proceed with making a booking, please click here to download the booking form and contact details.
**Please note, you can also use this booking form to book Partner Tours and/or Pre & Post Tours!


No. Pax        

Type of vehicle
(max passenger seats with luggages)       

Price Per Vehicle (RM) per one way      
1-2 Standard Sedan Car (2) RM180
1-2 Mercedes Car E-Class (2) RM280
4-5 Standard Combi (5) RM220


Note: Surcharge of 50% for transfer between 22:00 - 08:00 hours

Cost includes:

  • English speaking driver for combi and standard sedan card
  • Enhancement (mineral water - 1 bottle per guest)

Waiting time is 45 minutes. For flight delays beyond 45 minutes, an additional 30% per extra hour, or part thereof, will be charged to cover vehicle parking and extra staff costs.


IMPORTANT: No shows are subject to 100% charge.

Event Overview
  • Stephen Kent
    Stephen Kent

    Stephen Kent invents new synthetic chemistries and uses them to elucidate the molecular basis of protein function. His early work focused on understanding the underlying physical chemical principles of polymer-supported peptide synthesis ('solid phase peptide synthesis'), and on identifying and eliminating the chemical side reactions... ...Read More>>

  • Robert HodgesCropped
    Robert Hodges

    Robert Hodges  is Professor of Biochemistry & Molecular Genetics, Director, Program in Structural Biology and Biophysics and holder of the John Stewart Endowed Chair in Peptide Chemistry at the the University of Colorado Denver, School of Medicine, Aurora, CO, USA. Dr Hodges’ research spans diverse... ...Read More>>

  • Alan Trousoncropped
    Alan Trounson

    In Jan. 2008-present, Dr. Alan Trounson was appointed President of the California Institute for Regenerative Medicine, responsible for the management of the $3 billion fund for stem cell research in California (CIRM) . Under his leadership CIRM has constructed 12 new Californian Stem Cell Research......Read More>>

  • Rob Parton
    Rob Parton

    Robert Parton studied biochemistry in the UK before moving to the European Molecular Biology Laboratory in Heidelberg, Germany. He received Royal Society and EMBO postdoctoral fellowships before becoming a group leader in 1990 studying plasma membrane domains and cell surface dynamics. In 1996, he moved... ...Read More>>

  • Mike HannCropped
    Mike Hann

    Mike Hann completed his PhD  on Isosteric replacement studies in Enkephalins in 1980 and then worked as a medicinal chemist at Wyeth and then GD Searle in the UK. Around 1983 Mike developed an interest in computational chemistry which was then emerging as a... ...Read More>>

  • John Howlcropped
    John Howl

    Honorary Research Fellow, School of Biosciences, University of Birmingham, U.K. My current research efforts are focussed upon the development and applications of bioportides as a novel class of bioactive cell penetrating peptide (CPP). A variety of strategies have been employed to identify bioportide sequences that... ...Read More>>

  • Chris Porter v2
    Chris Porter

    Chris Porter is Professor of Pharmaceutics at the Monash Institute of Pharmaceutical Sciences and Associate Dean (Research) of the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University, Melbourne. He completed his undergraduate and graduate studies at the University of Nottingham before moving to Australia... ...Read More>>

  • Tom Sawyer v2
    Tomi Sawyer

    Tomi Sawyer is Chief Scientific Officer and Senior Vice-President of Drug Discovery and Innovative Technologies at Aileron Therapeutics in Cambridge, Massachusetts, USA, and is engaged in the development of a new therapeutic modality based on transforming Nature’s α−helix to Stapled Peptide drugs. He is concurrently... ...Read More>>

  • Bob Millarcropped
    Bob Millar

    Bob Millar is Director of the Mammal Research Institute at the University of Pretoria,  Director of the MRC Receptor Biology Unit at the University of Cape Town and Research Fellow at the Centre of Integrative Physiology at the University of Edinburgh. Previously he was Director... ...Read More>>

  • Justin Gooding
    Justin Gooding

    Scientia Professor Justin Gooding was born in Melbourne Australia.  He graduated with a B.Sc. (Hons) from Melbourne University before spending two years working for ICI Research on explosives.  He then returned to University obtaining a D.Phil. from the University of Oxford and received post-doctoral training... ...Read More>>

  • Joel Schneidercropped
    Joel Schneider

    Dr. Schneider received his B.Sc. in chemistry from the University of Akron in 1991, followed by a Ph.D. (1995) in chemistry from Texas A&M University.  After which, he became a George W. Raiziss Postdoctoral Fellow at the University of Pennsylvania (1996-1999) studying protein design.  He... ...Read More>>

  • Yoon Sik Leecropped
    Yoon Sik Lee

    Prof. Lee has received B. S. degree from Seoul National University (1974), and Ph. D from Rutgers University in organic chemistry (1981). He worked as a Post Doc. in the Department of Chemistry at the University of Chicago (1981-82). He is now a professor... ...Read More>>

  • Morten Meldal2
    Morten Meldal

    Professor Morten Meldal currently Head of the Nano Science Center at Copenhagen University, Copenhagen, Denmark. In 1981 he graduated as M.Sc. in Chemical Engineering from Technical University of Denmark. He took his PhD 1983 at Institute of Organic Chemistry, Technical University of Denmark, in "Synthesis... ...Read More>>

  • willie hildebrand v2
    William Hildebrand

    William Hildebrand characterizes the number and nature of peptides presented by the class I human leukocyte antigens (HLA) of cancerous and infected cells.  HLA class I molecules are responsible for conveying the internal health of human cells to the immune system.  Class I HLA accomplish... ...Read More>>

  • Michael Parkercropped
    Michael Parker

    Professor Michael Parker is Deputy Director of St. Vincent’s Institute of Medical Research in Melbourne where he is heads its Structural Biology Laboratory and the ACRF Rational Drug Discovery Centre. He is an NHMRC Senior Principal Research Fellow and a Professorial Fellow at the Bio21... ...Read More>>

  • Mark Wheatley
    Mark Wheatley

    Professor Mark Wheatley was appointed to the position of Chair of Biochemical Pharmacology in 2007 within the School of Biosciences at the University of Birmingham in the UK. His research addresses the structure and function of G-protein-coupled receptors (GPCRs) particularly those with peptide ligands. Understanding... ...Read More>>

  • Charlotte Hauser v3
    Charlotte Hauser

    Charlotte A.E. Hauser was trained in Chemistry at the University of Cologne, Germany, and did her Ph.D. in Molecular Biology at the Massachusetts Institute of Technology, USA. Following this, she joined INSERM in Paris, France, and the Max-Planck-Institute of Psychiatry in Munich, Germany. She is... ...Read More>>

  • Norelle DalyCropped
    Norelle Daly

    My research involves exploring the potential of peptides as drug candidates for therapeutic applications. Despite the significant potential of peptides in drug design because they can be highly potent and specific for a range of different drug targets, their inherent poor stability limits their application.... ...Read More>>

  • Iekhsan Othman
    Iekhsan Othman

    Prof Dr Iekhsan Othman is currently Deputy Head of School for Research and Head of Biomedical Sciences in the Jeffery Cheah School of Medicine and Health Sciences, Monash University, Sunway Campus, Malaysia.. He holds a BSc (Hons)  in biochemistry from Bristol University and a doctorate... ...Read More>>

  • James Tamcropped
    James Tam

    James P. Tam is the Director of the Drug Discovery Laboratory at Nanyang Technological University, Singapore.  He was the founding dean of the School of Biological Sciences, founding director of the double-degree program in Biomedical Science and Chinese Medicine, and the founding director of NTU......Read More>>

  • Phil Dawsoncropped
    Phil Dawson

    Philip Dawson is an Associate Professor in the Departments of Chemistry and Cell and Molecular Biology at The Scripps Research Institute (TSRI) in La Jolla, CA and is also the Associate Dean of Graduate Studies for the Kellogg School of Science and Technology at... ...Read More>>

  • Yoshio Hayashicropped
    Yoshio Hayashi

    Date of birth: December 14, 1960. EDUCATION: B.S.: Tokyo University of Pharmacy, Tokyo, Japan; graduated in March 1983. M.S.: Faculty of Pharmaceutical Science, Kyoto University, Kyoto, 1983-1985. Ph.D. Faculty of Pharmaceutical Science, Kyoto University, Kyoto, 1990, under the guidance of Emeritus Professor Haruaki Yajima and Professor... ...Read More>>

  • Matt Cooper
    Matthew Cooper

    Prof Matthew Cooper completed his PhD in Australia in 1995 and then spent 13 years in the UK, first at the University of Cambridge, then 9 years in start-ups and biotechnology companies. This involved innovation, fund raising, intellectual property generation, licensing, product development and commercialisation. ... ...Read More>>

  • Laszlo Otvos
    Laszlo Otvos

    Laszlo’s current research focuses on the development of antimicrobial peptides to resistant infections as well as agonists and antagonists to adipokine receptors.  His first-of-kind and optimized peptide analogs show promising preclinical advantages over conventional therapy against not only bacterial infections, but also metabolic and cardiovascular diseases,......Read More>>

  • Christie Hunter
    Christie Hunter

    Christie Hunter is the Director of Proteomic Applications at AB SCIEX. Christie and her team are focused on developing and testing innovative MS workflows for the quantitative analysis of proteins and peptides, and work collaboratively with the instrument, chemistry and software research groups. Her primary... ...Read More>>

  • David Jacksoncropped
    David Jackson

    David Jackson has been an active researcher over the last 35 years in the areas of immunology and immunochemistry. His recent research efforts are focused on the design, assembly and evaluation of new and innovative vaccines which have resulted in pre-clinical as well as... ...Read More>>

  • Yan Mei Licropped
    Yan-Mei Li

    Dr. Yan-Mei LI, Professor, Director of Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology (Ministry of Education). She graduated from Tsinghua University and received Ph.D. in 1992 under the supervision of Professor Yu-Fen Zhao. Then she worked with Prof. Dr. H. Waldmann as post-doctoral... ...Read More>>

  • Yasmina Abdiche
    Yasmina Abdiche

    *Dr Abdiche* is a Research Fellow at Pfizer’s biotherapeutic site in South San Francisco, California, formerly Rinat Neuroscience, which she joined in 2004. She leads the Biosensor Group within Protein Engineering that supports multiple projects at all stages of research using complementary label-based and label-free technologies... ...Read More>>

Registration Not yet available Register Now

ASN has secured a number of rooms at the conference venue (Shangri-La Golden Sands Resort) and the adjoining Shangri-La Rasa Sayang Resort & Spa at special conference rates, as per below.

Further Details:

If you do cancel your accommodation within 90 days prior to the conference commencing, you may be charged a large fee. For more information, please email Maryanne at

Scientific Content Up to Date
Submission Info


•  Peptide Design and Synthesis 
•  Peptidomimetics 
•  Peptides in Immunology 
•  Bioactive peptides 
•  GPCRs-structure based drug design 
•  Peptide-Vaccine delivery 
•  Proteomics, peptidomics and metabolomics 
•  Peptides and Nanotechnology 
•  Emerging Analytical Techniques 
•  Targeted Molecular Imaging 
•  Peptide Natural Products 
•  Peptide Antimicrobials 
•  Drug Delivery and Development 
•  Peptides: Towards the Clinic


You will need to copy and paste the abstract from your word document, into the online submission process.


The abstract content is to be no more than 300 words - this is not including your title, authors and references. 



The first step in uploading your abstract is to record your personal details on your own ‘dashboard’. If you have already completed it for your registration or another ASN event, you will not have to repeat this, just login to your ‘dashboard’ as a returning delegate. As you complete your registration you will receive a confirmation email. You will be able to upload your abstract via your personal 'dashboard.'


You can use your email and password to access your abstract submission at any time.


The presenting author must be the person submitting the abstract and they must do this from their own ‘dashboard’.


You can cut and paste your abstract in several simple steps. The benefits of this system are many but include:


i. Allowing you to preview your abstract and make modifications to your satisfaction.


ii. Ensuring you know your lodgement is completed as you will receive an immediate email confirmation


iii. Ensuring accurate indexing of all authors in the abstract book


iv. Ensuring consistent presentation of all abstracts in the proceedings (overarching formatting is imposed).


When you've finished the submission


You will receive a confirmation email with your Abstract Submission Reference Number. You can view or edit your abstract by returning to your dashboard.


If you do not receive this confirmation email, please contact ASN Events.


Changes can be made to your abstract until the scoring process begins. Just return to your Conference Dashboard and select the Edit option under Abstracts. The edit option will no longer appear once scoring has commenced.



Scientific Awards

Tregear Award

The Australian Peptide Association is pleased to announce the inaugural Tregear Award for outstanding research in the field of peptide chemistry, which will be made biannually at the Australian Peptide Conference. The award will consist of a medal and AUD $2000 to help defray expenses for attending the meeting.
All early career peptide scientists (10 years or less from award of their PhD thesis: allowances will be made for career disruptions)  working in Australia or New Zealand, or Australian or New Zealand residents working in the peptide field overseas, are eligible to apply. Potential awardees will be judged based on their c.v. relative to opportunity, their submitted abstract (which must be selected for an oral presentation at the Conference to be eligible) and the quality of their presentation at the conference.

The award will be judged by an Award Committee who reserve the right not to grant an award if they consider that none of the  candidates were of sufficient quality.

Nominations for the award must be made by Friday 28th June 2013 to the secretrary, A.Prof. Jackie Wilce (, and must include the following information:

Name of candidate

Evidence of PhD award date

Curriculum vitae of candidate including published research papers, research grants, promotions, honours and any other material relevant to the nomination

Details of Australian or New Zealand citizenship if working overseas

Concise statement of the candidate’s contribution to the field of peptide science and their vision for their future research  – supporting publications should be highlighted

Submitted conference abstract

Names of two referees with detailed knowledge of the candidate’s contributions to the field.

Sponsors Exhibitors
Sponsors / Supporters







Organising Agency
ASN Events Pty Ltd
PO Box 200 Balnarring, VIC 3926, Australia
+61 3 5983 2400
+61 3 5983 2223
Event map
Revelant Events